Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00305292 · ClinicalTrials.gov registry record · NA

Modafinil-Alcohol Interactions in Healthy Volunteers

A NA study, sponsored by University of California, San Francisco.

Terminated
Registry status
NA
Development phase
32
Enrollment target

NCT00305292 is a NA study that was terminated before completion, run by University of California, San Francisco. The registered enrollment target is 32 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00305292, a NA study, was terminated before completion, sponsored by University of California, San Francisco.

TERMINATED
Registry status
NA
Development phase
32 participants
Enrollment target

Study Summary

The UCSF Pain Clinical Research Center (PCRC) is conducting a study of the effects of modafinil (Provigil®; Vigiver, Alertec), alcohol and the combination on alertness, mood, visual motor and cognitive performance, and pain sensation. Modafinil is a stimulant drug marketed as a wakefulness and alertness promoting medication.

Interventions

  • DRUG Modafinil-Alcohol Interactions

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2006-03
Est. Completion 2006-08
Phase NA

What the Registry Record Tells You About NCT00305292

The ClinicalTrials.gov registry entry for NCT00305292 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Modafinil-Alcohol Interactions is the first listed.

NCT00305292 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00305292 about?

NCT00305292 is a clinical study titled "Modafinil-Alcohol Interactions in Healthy Volunteers". The UCSF Pain Clinical Research Center (PCRC) is conducting a study of the effects of modafinil (Provigil®; Vigiver, Alertec), alcohol and the combination on alertness, mood, visual motor and cognitive performance, and pain sensation. Modafinil is a stimulant drug marketed as a wakefulness and alert...

What is the current status of trial NCT00305292?

This trial is currently terminated. It is a NA study. The enrollment target is 32 participants. The study started on 2006-03. Estimated completion is 2006-08.

What interventions are being tested in trial NCT00305292?

The interventions under investigation include: Modafinil-Alcohol Interactions (DRUG).

Who is sponsoring clinical trial NCT00305292?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.